Knee News and Research

RSS

ProfNet network experts available to discuss timely issues in your coverage area

Below are experts from the ProfNet network that are available to discuss timely issues in your coverage area. You can also submit a query to the hundreds of thousands of experts in our network – it's easy and free!

27 Jun 2015

Overuse injuries more common in girls participating in high school sports

A new study performed by researchers at The Ohio State University Wexner Medical Center shows that when it comes to overuse injuries in high school sports, girls are at a much higher risk than boys.

24 Jun 2015

FDA accepts proposed brand name Invossa for TissueGene-C

TissueGene, Inc. today reported that the U.S. Food and Drug Administration (FDA) accepted the proposed brand name Invossa for TissueGene-C, the Company's proprietary product in development for treatment of osteoarthritis of the knee. FDA's acceptance of the proprietary brand name is subject to the Agency's final determination prior to any approval of the product's Biologic License Application (BLA) and market launch.

24 Jun 2015

Readmission to same hospital for post-surgical complications improves survival

Patients rehospitalized with complications after major surgery are 26% more likely to survive if they return to the hospital where they had their operation compared to those readmitted to a different hospital, according to a national study involving over 9 million Medicare patients in the USA, published in The Lancet.

22 Jun 2015

Heparin market in Europe estimated to reach USD 3,148.0 million by 2022

According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the Heparin Market Europe was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.

17 Jun 2015

New tissue 'scaffold' technology could one day help produce large organs

Scientists have developed a new tissue 'scaffold' technology that could one day enable the engineering of large organs. Research led by the Universities of Bristol and Liverpool has shown that it is possible to combine cells with a special scaffold to produce living tissue in the laboratory. It is hoped this can then be implanted into patients as a way of replacing diseased parts of the body.

17 Jun 2015

CyMedica Orthopedics closes $11.5 million Series A financing

CyMedica Orthopedics, Inc. announced today that it has closed an extension to its Series A financing. The Series A financing was led by investors Research Corporation Technologies, Inc., a Tucson-based venture capital firm, and California Technology Ventures, LLC, a Pasadena-based venture capital fund. The financing also included participation from existing investor Aphelion Capital (Mill Valley, CA) and the founding group of investors.

16 Jun 2015

Non-invasive accupoint electrical stimulation to treat Crohn's disease

An oral abstract presented at the International Neuromodulation Society 12th World Congress today unveiled a new collaboration between U.S. and Chinese into non-invasive accupoint electrical stimulation in Crohn's disease.

10 Jun 2015

BMJ adds new international orthopedic sports medicine journal to its portfolio

Global healthcare knowledge provider BMJ has added The Journal of ISAKOS: Joint Disorders & Orthopaedic Sports Medicine (JISAKOS) to its extensive portfolio of specialty journals, the company has announced.

10 Jun 2015

Control systems have potential to improve function of powered leg prostheses

A control system that incorporated electrical signals generated during muscle contractions and gait information resulted in improved real-time control of a powered prosthetic leg for different modes of walking (such as on level ground or descending stairs), according to a study in the June 9 issue of JAMA, a theme issue on the Americans with Disabilities Act.

10 Jun 2015

Ampio reports effects of Ampion in treating chronic pain caused by osteoarthritis of the knee

Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.

9 Jun 2015

Volunteer double act are ‘still game’ after 10 years

The Golden Jubilee’s very own ‘Jack and Victor’ have been honoured for serving Scotland’s national hospital for over a decade.

5 Jun 2015

Using technology to protect diabetics from foot amputations: an interview with Heleen Kist, HCi Viocare

When people don’t receive the body’s natural signals due to neuropathy, they can unknowingly be exposing their feet to conditions that are known to cause foot ulcers, such as repeated pressure and shear...

4 Jun 2015

New study reports that poor sleep habits increase pain in knee OA

A new study reports that patients with knee osteoarthritis (OA) who have poor sleep habits display greater central sensitization--an amplification of clinical pain. Findings published in Arthritis Care & Research, a journal of the American College of Rheumatology, further show OA patients who catastrophize--consumed by thoughts of pain--had increased central sensitization that was associated with greater clinical pain.

4 Jun 2015

Simple pre-surgical intervention can reduce S aureus surgical site infections

Implementation of a pre-surgical intervention that included screening for the bacteria Staphylococcus aureus, treating patients who were positive for this bacteria, and the administration of antibiotics based on these culture results was associated with a modest reduction in S aureus surgical site infections, according to a study in the June 2 issue of JAMA.

3 Jun 2015

Study on human growth hormone for ACL tear recovery receives funding from Mark Cuban Foundation

Funding from the Mark Cuban Foundation, run by the well-known owner of the Dallas Mavericks, will allow University of Michigan scientists and physicians to study how human growth hormone may aid recovery from an ACL tear - one of the most frequent, traumatic and dreaded knee injuries among athletes.

1 Jun 2015

FVCG portfolio companies selected to present research at Bio International 2015

Actinobac Biomed, NovoPedics, Inc. and MentiNova, Inc., three biotech start-up companies originally funded with investments from Foundation Venture Capital Group (FVCG), have been selected to present their research at Bio International 2015 as part of the Start-Up Stadium and Company Presentation forums offered at the Conference, announced FVCG President James M. Golubieski.

30 May 2015

Knee News and Research

ProfNet network experts available to discuss timely issues in your coverage area

Overuse injuries more common in girls participating in high school sports

FDA accepts proposed brand name Invossa for TissueGene-C

Readmission to same hospital for post-surgical complications improves survival

Heparin market in Europe estimated to reach USD 3,148.0 million by 2022

New tissue 'scaffold' technology could one day help produce large organs

CyMedica Orthopedics closes $11.5 million Series A financing

Non-invasive accupoint electrical stimulation to treat Crohn's disease

BMJ adds new international orthopedic sports medicine journal to its portfolio

Control systems have potential to improve function of powered leg prostheses

Ampio reports effects of Ampion in treating chronic pain caused by osteoarthritis of the knee

Volunteer double act are ‘still game’ after 10 years

Using technology to protect diabetics from foot amputations: an interview with Heleen Kist, HCi Viocare

New study reports that poor sleep habits increase pain in knee OA

Simple pre-surgical intervention can reduce S aureus surgical site infections

Study on human growth hormone for ACL tear recovery receives funding from Mark Cuban Foundation

FVCG portfolio companies selected to present research at Bio International 2015

Zimmer finalizes divestiture agreements in furtherance of pending acquisition of Biomet

LegWorks receives grant to produce affordable prosthetic knee for amputees in developing countries

Mayo Clinic hospitals earn top-tier High Performing distinction in U.S. News & World Report ratings

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News